ViaCyte | Regenerative Medicine Therapies for Diabetes
Islet Cell Replacement Therapy for Insulin-Dependent Diabetes - CADTH Issues in Emerging Health Technologies - NCBI Bookshelf
Articles with ViaCyte, Inc.
Gore joins ViaCyte's quest for a functional type 1 diabetes cure - MedCity News
Finally, a possible long-term treatment for type 1 diabetes | UCI Health | Orange County, CA
ViaCyte treats first patients in PEC-Direct stem cell trial for type 1 diabetes | The Stem Cellar
Producing insulin for people who can't | The Stem Cellar
Product Pipeline for Insulin-Requiring Diabetes Treatments
JDRF Applauds the Small Business Innovative Research Award to ViaCyte
ViaCyte's Future 'Functional Diabetes Cure' for Diabetes
ViaCyte receives funding towards 'functional cure' for diabetes
Vertex to acquire stem cell-derived diabetes treatment maker ViaCyte
ViaCyte (@ViaCyte) / Twitter
ViaCyte's Sweet Three-Pronged Attack against Type 1 Diabetes
Product Pipeline for Insulin-Requiring Diabetes Treatments
Stem Cell-derived Treatment One Step Closer to Type 1 Diabetes Cure
ViaCyte | Regenerative Medicine Therapies for Diabetes
Type 1 Diabetes Cures in Spotlight with Vertex Deal
ViaCyte | Regenerative Medicine Therapies for Diabetes
ViaCyte (@ViaCyte) / Twitter
Stem Cell Implants Could Cure Diabetes | Healthcare Packaging
ViaCyte (@ViaCyte) / Twitter
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient - The Niche
ViaCyte Advances Cell Replacement Therapy for High Risk Type 1 Diabetes | The Stem Cellar
